Work

Phase II Study of High Dose Lenalidomide as Initial Treatment for Older Acute Myeloid Leukemia Patients: Early Results Show a Significant Reduction of Bone Marrow Blasts after 14 Days of Therapy.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.916.916

Authors: Todd A. Fehniger, Alissa Nelson, Kathryn Trinkaus, Camille N. Abboud, Amanda F. Cashen, John F. DiPersio, Timothy A. Graubert, Timothy J. Ley, Michael H. Tomasson, Geoffrey L. Uy, Matthew J. Walter, Peter Westervelt, Ravi Vij

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564833252

FWCI: 1.481

Cites:

Cited by: 8

Related to: 10